Research and development

ABNOBA GmbH is one of the few medium-sized companies in Germany that researches and develops new pharmaceutical procedures. The core area of our medical research is oncology.

Issues concerning immunology, cytotoxicity 1), prevention of recurrence 2) and the effect of our medicines on prolonging survival times form the focus of our research into herbal medicinal products, particularly mistletoe therapy.

1) Cytotoxicity means the direct, devitalising effect on cells, i.e. the tumour cells.
2) A therapy to prevent recurrence aims to prevent the return of a cancer.